LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.

Reppe, Katrin / Radünzel, Peter / Dietert, Kristina / Tschernig, Thomas / Wolff, Thorsten / Hammerschmidt, Sven / Gruber, Achim D / Suttorp, Norbert / Witzenrath, Martin

Infection and immunity

2015  Volume 83, Issue 12, Page(s) 4617–4629

Abstract: ... immunostimulation with MALP-2 in influenza virus-infected mice improved pulmonary bacterial elimination and ... in influenza A virus (IAV)-infected mice on the course of subsequent pneumococcal superinfection. Female C57BL/6N mice ... treatment of IAV-infected mice increased survival rates and reduced hypothermia and body weight loss after ...

Abstract Pulmonary infection with influenza virus is frequently complicated by bacterial superinfection, with Streptococcus pneumoniae being the most prevalent causal pathogen and hence often associated with high morbidity and mortality rates. Local immunosuppression due to pulmonary influenza virus infection has been identified as a major cause of the pathogenesis of secondary bacterial lung infection. Thus, specific local stimulation of the pulmonary innate immune system in subjects with influenza virus infection might improve the host defense against secondary bacterial pathogens. In the present study, we examined the effect of pulmonary immunostimulation with Toll-like receptor 2 (TLR-2)-stimulating macrophage-activating lipopeptide 2 (MALP-2) in influenza A virus (IAV)-infected mice on the course of subsequent pneumococcal superinfection. Female C57BL/6N mice infected with IAV were treated with MALP-2 on day 5 and challenged with S. pneumoniae on day 6. Intratracheal MALP-2 application increased proinflammatory cytokine and chemokine release and enhanced the recruitment of leukocytes, mainly neutrophils, into the alveolar space of IAV-infected mice, without detectable systemic side effects. Local pulmonary instillation of MALP-2 in IAV-infected mice 24 h before transnasal pneumococcal infection considerably reduced the bacterial number in the lung tissue without inducing exaggerated inflammation. The pulmonary viral load was not altered by MALP-2. Clinically, MALP-2 treatment of IAV-infected mice increased survival rates and reduced hypothermia and body weight loss after pneumococcal superinfection compared to those of untreated coinfected mice. In conclusion, local immunostimulation with MALP-2 in influenza virus-infected mice improved pulmonary bacterial elimination and increased survival after subsequent pneumococcal superinfection.
MeSH term(s) Animals ; Coinfection ; Female ; Hypothermia/prevention & control ; Immunity, Innate ; Immunization ; Immunologic Factors/pharmacology ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza A Virus, H1N1 Subtype/pathogenicity ; Lipopeptides/pharmacology ; Lung/drug effects ; Lung/immunology ; Lung/microbiology ; Lung/virology ; Macrophage Activation/drug effects ; Mice ; Mice, Inbred C57BL ; Neutrophil Infiltration/drug effects ; Neutrophils/drug effects ; Neutrophils/immunology ; Neutrophils/microbiology ; Neutrophils/virology ; Orthomyxoviridae Infections/drug therapy ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/mortality ; Orthomyxoviridae Infections/virology ; Pneumonia, Pneumococcal/drug therapy ; Pneumonia, Pneumococcal/immunology ; Pneumonia, Pneumococcal/microbiology ; Pneumonia, Pneumococcal/mortality ; Streptococcus pneumoniae/drug effects ; Streptococcus pneumoniae/immunology ; Streptococcus pneumoniae/pathogenicity ; Survival Analysis ; Weight Loss/drug effects
Chemical Substances Immunologic Factors ; Lipopeptides ; macrophage stimulatory lipopeptide 2 (DZX5IUA94D)
Language English
Publishing date 2015-09-14
Publishing country United States
Document type Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 218698-6
ISSN 1098-5522 ; 0019-9567
ISSN (online) 1098-5522
ISSN 0019-9567
DOI 10.1128/IAI.00948-15
Shelf mark
Zs.A 684: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top